(Q44030644)

29 November 2017

title

Concomitant symptoms itemized in the Reflux Disease Questionnaire are associated with attenuated heartburn response to acid suppression (English)

1 reference

29 November 2017

1 reference

Peter J Kahrilas

1

1 reference

29 November 2017

Andreas Jonsson

2

1 reference

29 November 2017

Hans Denison

3

1 reference

29 November 2017

Börje Wernersson

4

1 reference

29 November 2017

Nesta Hughes

5

1 reference

29 November 2017

Colin W Howden

6

1 reference

29 November 2017

language of work or name

English

0 references

publication date

10 July 2012

1 reference

The American Journal of Gastroenterology

29 November 2017

published in

1 reference

29 November 2017

volume

107

1 reference

29 November 2017

issue

9

1 reference

29 November 2017

page(s)

1354-1360

1 reference

The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus

29 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.197

Initial validation of a diagnostic questionnaire for gastroesophageal reflux disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.197

Accuracy of the diagnosis of GORD by questionnaire, physicians and a trial of proton pump inhibitor treatment: the Diamond Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.197

Development of the GerdQ, a tool for the diagnosis and management of gastro-oesophageal reflux disease in primary care

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.197

Response of regurgitation to proton pump inhibitor therapy in clinical trials of gastroesophageal reflux disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.197

A randomized, comparative trial of a potassium-competitive acid blocker (AZD0865) and esomeprazole for the treatment of patients with nonerosive reflux disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.197

A randomized, comparative study of three doses of AZD0865 and esomeprazole for healing of reflux esophagitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.197

Regurgitation is less responsive to acid suppression than heartburn in patients with gastroesophageal reflux disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.197

Response of unexplained chest pain to proton pump inhibitor treatment in patients with and without objective evidence of gastro-oesophageal reflux disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.197

Insights into gastroesophageal reflux disease-associated dyspeptic symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.197

Effect of profound acid suppression in functional dyspepsia: a double-blind, randomized, placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.197

Double blind, randomised, placebo controlled study of four weeks of lansoprazole for the treatment of functional dyspepsia in Chinese patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.197

Lansoprazole in the treatment of functional dyspepsia: two double-blind, randomized, placebo-controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.197

Efficacy of omeprazole in functional dyspepsia: double-blind, randomized, placebo-controlled trials (the Bond and Opera studies).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.197

21 January 2018

Identifiers

DOI

10.1038/AJG.2012.197

1 reference

Dimensions Publication ID

29 November 2017

1047359404

0 references

1 reference